RELMABI

Serial Number 99374398
641

Registration Progress

Application Filed
Sep 4, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Apr 22, 2026 80 days

Trademark Image

RELMABI

Basic Information

Serial Number
99374398
Filing Date
September 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jan 22, 2026
Application
Pending
Classes
005

Rights Holder

Teva Pharmaceuticals International GmbH

11
Address
Schluselstrasse 12
Jona 8645
CH

Ownership History

Teva Pharmaceuticals International GmbH

Original Applicant
11
Jona CH

Legal Representation

Attorney
Laurence Rickles

USPTO Deadlines

Next Deadline
80 days remaining
Non-Final Action E-Mailed
Due Date
April 22, 2026
Extension Available
Until July 22, 2026

Application History

7 events
Date Code Type Description Documents
Jan 22, 2026 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 22, 2026 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 22, 2026 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 20, 2026 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 4, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 4, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 4, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, gastro-intestinal diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification

International Classes
005